ReviewFrontiers in pharmacology2015
Syzygium cumini (L.) skeels: a prominent source of bioactive molecules against cardiometabolic diseases.
Review in Frontiers in pharmacology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 114 citations in OpenAlex.
- Bioactivity-Guided Identification of Metabolites fromMolecules (Basel, Switzerland) · 2026Article
- LC-MS/MS-based metabolomic profiling of Syzygium cumini (L.) Skeels identifies key phytochemicals associated with α-amylase inhibition and antioxidant activity.Scientific reports · 2026Article
- Phytochemical profiling of Syzygium nervosum fruit pulp extracts and their modulatory effects on oxidative stress and cytokine production.BMC complementary medicine and therapies · 2026Article
- Untargeted metabolomics reveals3 Biotech · 2025Article
- Evaluation of Antioxidant, Xanthine Oxidase-Inhibitory, and Antibacterial Activity ofPlants (Basel, Switzerland) · 2025Article
- Effect ofCardiovascular & hematological agents in medicinal chemistry · 2025Article
- Ethnomedicinal Uses, Phytochemistry, and Anticancer Potentials of African Medicinal Fruits: A Comprehensive Review.Pharmaceuticals (Basel, Switzerland) · 2023Review
- Major Bioactive Compounds from Java Plum Seeds: An Investigation of Its Extraction Procedures and Clinical Effects.Plants (Basel, Switzerland) · 2023Review
- Recent Advances in Using Natural Antibacterial Additives in Bioactive Wound Dressings.Pharmaceutics · 2023Review
- Exploring the Potential ofAnimals : an open access journal from MDPI · 2022Review
- Molecular docking and pharmacokinetic prediction of phytochemicals fromBiotechnologia · 2022Article
- In Vivo Anti-Inflammatory, Analgesic, Muscle Relaxant, and Sedative Activities of Extracts fromEvidence-based complementary and alternative medicine : eCAM · 2022Article
- Article
- Isolation and Identification of Endophytic Fungi fromTheScientificWorldJournal · 2022Article
- Regulation of Key Antiplatelet Pathways by Bioactive Compounds with Minimal Bleeding Risk.International journal of molecular sciences · 2021Review
- Evaluation of the anti-gout effect ofMedicine and pharmacy reports · 2021Article
- Antidiabetic Potential ofThe Yale journal of biology and medicine · 2020Review
- Quercetin, caffeic acid and resveratrol regulate circadian clock genes and aging-related genes in young and old human lung fibroblast cells.Molecular biology reports · 2020Article
- In vivo assessment of anticoagulant and antiplatelet effects of Syzygium cumini leaves extract in rabbits.BMC complementary and alternative medicine · 2019Article
- Hematologic changes and splenic index on malaria mice models givenVeterinary world · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Syzygium cumini (Myrtaceae) is a worldwide medicinal plant traditionally used in herbal medicines due to its vaunted properties against cardiometabolic disorders, which include: antihyperglycemic, hypolipemiant, antiinflammatory, cardioprotective, and antioxidant activities. These properties have been attributed to the presence of bioactive compounds such as phenols, flavonoids, and tannins in different parts of the plant, albeit the knowledge on their mechanisms of action is scarce. This mini-review highlights the cardiometabolic properties of S. cumini by correlating its already identified phytochemicals with their described mechanisms of action. Data herein compiled show that some compounds target multiple metabolic pathways; thereby, becoming potential pharmacological tools. Moreover, the lack of clinical trials on S. cumini usage makes it a fruitful field of interest for both scientific community and pharmaceutical industry.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.